A clinical trial at Bellvitge Hospital shows that the experience of patients undergoing chest drain removal after heart surgery improves with the incorporation of this immersive practic
Bellvitge University Hospital (HUB) is set to introduce advanced magnetic resonance imaging (MRI) equipment within the premises of the Delta building, its hub of excellence in Neuroscience and Neurosurgery. This cutting-edge apparatus is specifically designed to cater to the diagnosis and treatment of patients grappling with a spectrum of neurological disorders, encompassing both medical and surgical cases. It will entirely integrate into the hospital's operational workflows.
Dr Josep Manuel Menchon, group leader at IDIBELL and Head of Psychiatry Service at Bellvitge University Hospital, participates in a pioneering study led by the University of Hertfordshire (UK) to address and reduce the risks of harmful internet use among adolescents.
According to the results of the APRIL study, in which the Bellvitge University Hospital (HUB) and IDIBELL have participated, ApTOLL has shown good safety in 151 patients with acute ischaemic stroke. The study also highlights that preliminary efficacy results show that the drug significantly reduces mortality and long-term functional disability.